Description
Product Introduction
It is widely accepted that IgM provides the first line of defense during viral infections, followed by the generation of adaptive, high affinity IgG responses for long term immunity and immunological memory. Therefore testing of COVID-19 IgM and IgG antibodies is an effective method for the rapid diagnosis of COVID-19 infection. Furthermore, detection of COVID-19 IgM antibodies tends to indicate a recent exposure to COVID-19, whereas detection of COVID-19 IgG antibodies indicates a later stage of infection. Thus, this combined antibody test could provide information on the st age of infection as well.
- I Product Advantages
1. Easy to use
2. Can be used to test whole blood, serum and plasma
3. 4 simple steps
4. Results in 15 min
5. Tests for 2 antibodies
6. Easy to read results
7. No equipment needed
8. No sample transport
III. Product Manual
4 Simple steps:
a. Extract blood sample
b. Add sample to sample port
c. Add 2-3 drops of buffer solution to sample port
d. Read results in 15 minutes
- Comparison with PCR Nucleic Acid tests
| PCR Nucleic Acid Tests IgM | IgM/IgG Combined Test | ||
| Turnaround time | >1 hour | 15 min | |
| Facility Requirement | PCR Laboratory | None | |
| Operation | Requires technicians | Whole blood, serum and plasma can be used | |
| Expensive equipment | Easy operation | ||
| Complicated operation | Test anywhere, any time | ||
| Prone to false negatives | Easy-to-read results | ||
| Transport/Storage | Freezing conditions | Room Temperature | |
| Clinical Value | Freezing conditions
Commonly used standard |
Highly specific, real-time
monitoring |
|
